TNF inhibitors are drugs that help stop inflammation. They're used to treat diseases like rheumatoid arthritis (RA), juvenile arthritis, psoriatic arthritis, plaque psoriasis, ankylosing spondylitis, ulcerative colitis (UC), and Crohn's disease.They're also called TNF blockers, biologic therapies, or anti-TNF drugs.

The global Tumor Necrosis Factor (TNF) Inhibitor Drugs market is valued at xx million US$ in 2020 is expected to reach xx million US$ by the end of 2026, growing at a CAGR of xx% during 2021-2026.
This report focuses on Tumor Necrosis Factor (TNF) Inhibitor Drugs volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Tumor Necrosis Factor (TNF) Inhibitor Drugs market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan etc.
Market Segment Analysis
The research report includes specific segments by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2015 to 2026. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type, the Tumor Necrosis Factor (TNF) Inhibitor Drugs market is segmented into
Remicade
Humira
Cimzia
Simponi
Others

Segment by Application
Online Pharmacies
Specialty Pharmacies
Hospital Pharmacies

Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Market: Regional Analysis
The Tumor Necrosis Factor (TNF) Inhibitor Drugs market is analysed and market size information is provided by regions (countries). The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type and by Application segment in terms of sales and revenue for the period 2015-2026.
The key regions covered in the Tumor Necrosis Factor (TNF) Inhibitor Drugs market report are:
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Market: Competitive Analysis
This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2015 to 2019.
The major players in global Tumor Necrosis Factor (TNF) Inhibitor Drugs market include:
Takeda Pharmaceuticals
Amgen
AbbVie
Pfizer
Novartis
Johnson and Johnson
UCB
Merck
Abbott Laboratories
Biogen
Gilead Sciences
Thermo Fisher Scientific
Bristol-Myers Squibb
Astellas Pharma
AstraZeneca
Eli Lilly and Company
Roche
Sanofi